Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulcrum Therapeutics (FULC) Capital Expenditures (2018 - 2026)

Fulcrum Therapeutics (FULC) has 9 years of Capital Expenditures data on record, last reported at $8000.0 in Q1 2026.

  • On a quarterly basis, Capital Expenditures changed N/A to $8000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $322000.0, a 28.8% increase, with the full-year FY2025 number at $314000.0, up 12.95% from a year prior.
  • Capital Expenditures reached $8000.0 in Q1 2026 per FULC's latest filing, down from $155000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for FULC hit a ceiling of $1.3 million in Q2 2022 and a floor of -$1.8 million in Q4 2022.
  • A 5-year average of $75600.0 and a median of $98000.0 in 2024 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: surged 515.0% in 2022, then plummeted 103.14% in 2024.
  • Tracing FULC's Capital Expenditures over 5 years: stood at -$1.8 million in 2022, then soared by 104.23% to $77000.0 in 2023, then increased by 27.27% to $98000.0 in 2024, then skyrocketed by 58.16% to $155000.0 in 2025, then plummeted by 94.84% to $8000.0 in 2026.
  • Business Quant data shows Capital Expenditures for FULC at $8000.0 in Q1 2026, $155000.0 in Q4 2025, and $159000.0 in Q3 2025.